Streetbeat News

Stock Prices

TECX

Tectonic Therapeutic (NASDAQ:TECX) reported a Q2 EPS loss of $(4.34), significantly missing the analyst consensus estimate of $(1.50) by 189.33%. This represents a 49% improvement over the $(8.51) loss per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:11 pm

GOOG

GOOGL

The Department of Justice (DOJ) is investigating Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) for its dominance in the search market, with potential outcomes including a breakup or restructuring of the company. Analysts suggest that a breakup could be beneficial for shareholders, potentially leading to higher valuations for individual business units like YouTube. The legal process could take one to two years, and the stock has seen a 2.3% decline amid the news.

Portfolio Pulse from Chris Katje

August 14, 2024 | 8:11 pm

BEAT

HeartBeam (NASDAQ:BEAT) reported a Q2 2024 GAAP EPS of $(0.19), missing the analyst consensus estimate of $(0.17) by 11.76%. This represents an 18.75% increase in losses compared to $(0.16) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:10 pm

KOD

Kodiak Sciences (NASDAQ:KOD) reported a Q2 EPS of $(0.86), beating the analyst consensus estimate of $(1.19) by 27.73%. This represents a 43.79% improvement over the $(1.53) loss per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:10 pm

PGEN

Precigen (NASDAQ:PGEN) reported Q2 2024 GAAP EPS of $(0.23), missing the $(0.10) estimate by 130%. Sales were $717K, missing the $1.28M estimate by 43.98%. This represents a 187.5% decrease in EPS and a 59.42% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:10 pm

TMC

TMC Metals (NASDAQ:TMC) reported a Q2 2024 GAAP EPS of $(0.06), missing the analyst consensus estimate of $(0.05) by 20%. This represents a 20% increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:10 pm

LYRA

Lyra Therapeutics (NASDAQ:LYRA) reported Q2 earnings per share (EPS) of $(0.74), missing the analyst estimate of $(0.33) by 124.24%. However, the company reported sales of $598K, beating the estimate of $350K by 70.86%.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:09 pm

GWH

ESS Tech (NYSE:GWH) reported Q2 2024 GAAP EPS of $(0.12), missing the $(0.10) estimate. Sales were $348K, significantly below the $3.49M estimate and down 87.69% from last year's $2.83M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:09 pm

AVBP

ArriVent BioPharma (NASDAQ:AVBP) reported a Q2 EPS of $(0.65), missing the analyst consensus estimate of $(0.54) by 20.37%. This represents a significant improvement from the $(10.79) per share loss in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:08 pm

ABSI

Absci (NASDAQ: ABSI) reported Q2 2024 GAAP EPS of $(0.22), missing the $(0.20) estimate. Sales were $1.27M, missing the $1.91M estimate. EPS improved by 51.11% YoY, but sales decreased by 62.28% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:08 pm